Salvia divinorum

Salvia, salvinorins & derivatives



Jump to:



Page 2

Willmore-Fordham et al. (2007). The hallucinogen derived from Salvia divinorum, salvinorin a, has κ-opioid agonist discriminative stimulus effects in rats. Neuropharmacology.

Babu, McCurdy & Boyer (2008). Opioid receptors and legal highs: Salvia divinorum and Kratom. Clinical Toxicology.

Beerepoot et al. (2008). Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole. Neuroscience Letters.

Braida et al. (2008). Involvement of κ-opioid and endocannabinoid system on Salvinorin A-induced reward. Biological Psychiatry.

Capasso et al. (2008). Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. British Journal of Pharmacology.

Capasso et al. (2008). The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice. Neurogastroenterology and Motility.

Griffin, Miller & Khey (2008). Legally high? Legal considerations of Salvia divinorum. Journal of Psychoactive Drugs.

Hooker et al. (2008). Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans. NeuroImage.

Hoover et al. (2008). Internet access to Salvia divinorum: Implications for policy, prevention, and treatment. Journal of Substance Abuse Treatment.

Kempf et al. (2008). Identification of sinicuichi alkaloids in human serum after intoxication caused by oral intake of a Heimia salicifolia extract. Forensic Science International.

Khey, Miller & Griffin (2008). Salvia divinorum use among a college student sample. Journal of Drug Education.

Kikura-Hanajiri (2008). [Analytical data of designated substances (Shitei-Yakubutsu) controlled by the Pharmaceutical Affairs Law in Japan, part I: GC-MS and LC-MS]. Yakugaku Zasshi.

Lange et al. (2008). College student use of Salvia divinorum. Drug and Alcohol Dependence.

Maruyama et al. (2008). [Authentication and ultra performance liquid chromatography (UPLC)/MS analysis of magic mint, Salvia divinorum and its related plants]. Yakugaku Zasshi.

McDonough et al. (2008). The detection and quantitative analysis of the psychoactive component of Salvia divinorum, salvinorin A, in human biological fluids using liquid chromatography-mass spectrometry. Journal of Analytical Toxicology.

Tsujikawa et al. (2008). Determination of salvinorin A and salvinorin B in Salvia divinorum-related products circulated in Japan. Forensic Science International.

Albertson & Grubbs (2009). Subjective effects of Salvia divinorum: LSD- or marijuana-like? Journal of Psychoactive Drugs.

Baker et al. (2009). Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats. Psychopharmacology.

Braida (2009). Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. British Journal of Pharmacology.

Butelman et al. (2009). Unconditioned behavioral effects of the powerful k-opioid hallucinogen Salvinorin A in nonhuman primates: Fast onset and entry into cerebrospinal fluid. The Journal of Pharmacology and Experimental Therapeutics.

Fichna et al. (2009). Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors. Neurogastroenterology and Motility.

Fichna et al. (2009). Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction. Drug News & Perspectives.

Fontana et al. (2009). Synthetic studies on neoclerodane diterpenes from Salvia splendens: oxidative modifications of ring A. Tetrahedron.

Jermain & Evans (2009). Analyzing salvia divinorum and its active ingredient salvinorin a utilizing thin layer chromatography and gas chromatography/mass spectrometry. Journal of Forensic Sciences.

Kutrzeba, Ferreira & Zjawiony (2009). Salvinorins J from Salvia divinorum: mutarotation in the neoclerodane system. Journal of Natural Products.

Miller et al. (2009). Trippin' on Sally D: Exploring predictors of Salvia divinorum experimentation. Journal of Criminal Justice.

Morani et al. (2009). Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats. Pharmacology, Biochemistry and Behavior.

Przekop & Lee (2009). Persistent psychosis associated with Salvia divinorum use. The American Journal of Psychiatry.

Simpson et al. (2009). Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors. Organic & Biomolecular Chemistry.

Teksin et al. (2009). Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. European Journal of Pharmaceutics and biopharmaceutics.

Tsujikawa et al. (2009). In vitro stability and metabolism of salvinorin A in rat plasma. Xenobiotica.

Yang et al. (2009). Synthesis and biological evaluation of C-12 triazole and oxadiazole analogs of salvinorin A. Bioorganic & Medicinal Chemistry Letters.

Baggott et al. (2010). Use patterns and self-reported effects of salvia divinorum: An internet-based survey. Drug and Alcohol Dependence.

Breton et al. (2010). Prolonged hallucinations and dissociative self mutilation following use of Salvia divinorum in a bipolar adolescent girl. Journal of Substance Use.

Hanson (2010). Natural products from the hallucinogenic sage. Science Progress.

Kennedy & Wiseman. Direct analysis of Salvia divinorum leaves for salvinorin A by thin layer chromatography and desorption electrospray ionization multi-stage tandem mass spectrometry. Rapid Communications in Mass Spectrometry.

Killinger, Peet & Baker (2010). Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague–Dawley rats. Pharmacology, Biochemistry and Behavior.

Kutrzeba et al. (2010). Intramolecular transacetylation in salvinorins D and E. Journal of Natural Products.

Lange et al. (2010). Salvia divinorum: Effects and use among Youtube users. Drug and Alcohol Dependence.

Lee et al. (2010). Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A. Bioorganic & Medicinal Chemistry Letters.

Nyi et al. (2010). Influence of age on Salvia divinorum use: Results of an Internet survey. Journal of Psychoactive Drugs.

Phipps & Butterweck (2010). A new digitized method of the compulsive gnawing test revealed dopaminergic activity of salvinorin A in vivo. Planta Medica.

Walentiny et al. (2010). Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents. Psychopharmacology.

Ahern & Greenberg (2011). Psychoactive herb use and youth: a closer look at Salvia divinorum. Journal of Psychosocial Nursing and Mental Health Services.

Aviello et al. (2011). Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo.

Braida et al. (2011). Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats. International Journal of Toxicology.

Casselman & Heinrich (2011). Novel use patterns of Salvia divinorum: unobtrusive observation using YouTube™. Journal of Ethnopharmacology.

Cunningham, Rothman & Prisinzano (2011). Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacological Reviews.

Fichna et al. (2011). Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum. Neurogastroenterology and Motility.

Ford, Watkins & Blumenstein (2011). Correlates of Salvia divinorum use in a national sample: findings from the 2009 National Survey on Drug Use and Health. Addictive Behaviors.

Jenks, Walker & Kim (2011). Evolution and origins of the Mazatec hallucinogenic sage, Salvia divinorum (Lamiaceae): a molecular phylogenetic approach. Journal of Plant Research.